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ABSTRACT 
Incorporating Disease-Oriented Smoking Cessation Education into the Care of Smokers 
with Peripheral Arterial Disease 
 
Donte Newsom 
 
Background and Significance 
Smoking is a major health issue in the United States, with nearly 18% of the population 
being reported as active smokers.  Smoking is a contributing factor to many chronic diseases, 
such as peripheral arterial disease, and is a public health concern significant to nursing practice. 
 
Problem Statement 
Despite evidence of the detriments of smoking, many patients with peripheral arterial 
disease receive minimal smoking cessation education, and cessation aides are rarely utilized.  
  
Project Design  
A disease-oriented smoking cessation education intervention was developed modeling the 
5 A’s of smoking cessation and utilized for active smokers with peripheral arterial disease.  This 
pilot study evaluated the feasibility of implementing the practice change in a specialty practice. 
 
Evaluation Plan  
Patients’ number of cigarettes smoked daily, readiness to change, and attitudes towards 
the intervention were evaluated.  Percent of eligible people who obtained the intervention were 
tracked to evaluate process. The cost-effectiveness of the intervention was a major consideration. 
 
Results  
The intervention reached 69% of those who met inclusion criteria.  Most participants 
found the intervention helpful.  Participants reduced smoking by 60.8% and moved forward 
toward smoking cessation by 1.0 stage of change.  A cost/benefit analysis revealed the 
intervention was cost-effective. 
 
Recommendations  
This cost-effective practice change should be implemented across a variety of practice 
settings as part of comprehensive healthcare approach to smoking cessation. 
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Incorporating Disease-Oriented Smoking Cessation Education into the Care of Smokers with 
Peripheral Arterial Disease 
Smoking is a major public health hazard that is of concern to all levels of nursing 
practice. Prevention is a key role of the advanced practice nurse, and smoking is a preventable 
risk factor for many diseases. One of the many diseases that is attributable to smoking is 
peripheral arterial disease (Hennrikus et al., 2010).  Despite evidence of the detriments of 
smoking, many patients receive minimal education related to smoking cessation, and cessation 
aides are rarely utilized (Aiman et al., 2014; Mannava & Money, 2007; Verma et al., 2011).  This 
project evaluated the feasibility of implementing an intervention that identified current smokers 
with peripheral arterial disease in a small specialty practice and provided them with disease-
oriented smoking cessation education to help prevent disease recurrence or worsening. 
Background 
Working as a nurse practitioner at a small vascular surgery practice in North Central West 
Virginia offers many challenges, but also many opportunities. The patient population is rural, 
97% white, and the majority are from a lower socioeconomic background.  Almost 24% of 
patients are current smokers, with an additional 38% being former smokers.  Only 37% of 
patients have never smoked.  Despite its challenges, being able to work and help patients from 
one’s own community is often rewarding.  The providers and staff are committed to providing 
excellent patient care to patients diagnosed with a variety of vascular diseases, such as 
abdominal aortic aneurysms, carotid artery disease, peripheral arterial disease, venous 
insufficiency, and wounds.  Among these, peripheral arterial disease is the most prevalent and 
lifestyle impacting disease and was the focus for the purposes of this project. 
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Problem Statements 
Smoking is a major health issue in the United States, with nearly 18% of the United 
States population being reported as active smokers (CDC, 2015).  Smoking is a leading 
contributor to death and disease.  More than 16 million people in the U.S. have diseases caused 
by smoking, and one in five deaths in the U.S. are caused by smoking, totaling nearly 480,000 
each year.  Subsequently, smoking is a major economic burden, costing the medical system $193 
billion a year (HealthyPeople.gov). 
Peripheral arterial disease (PAD) is a vascular disorder involving the narrowing of the 
arterial blood vessels distal to the aortic arch (Sontheimer, 2006).  The reported prevalence of 
PAD varies widely between studies and is affected by age and other risk factors; it affects 3-10% 
of the general population, and 15-20% of adults over 70 years of age (Hennion & Siano, 2013).  
In one study, when evaluating smoking in the sub-population of people with peripheral arterial 
disease, it was found that approximately 26% smoke, and as many as 79% have a smoking 
history, either current or former (Dunkley, et al., 2007).  Smoking is a top modifiable risk factor 
contributing to PAD, second only to diabetes (Alexopoulos, Vlachopoulos, & Stefanadis, 2010; 
Conen et al., 2011; Hennrikus et al., 2010; Federman and Kravetz, 2007; Katsiki, Papadopoulou, 
Fachantidou, & Mikhailidis, 2013; Lu, Mackay, & Pell, 2014; Moyer, 2013; Muir, 2009; 
Paraskevas, Papas, Pavlidis, Bessias, & Andrikopoulos, 2008; Simmons, Steffen, & Sanders, 
2012; Sontheimer, 2006; Steffen, Duprez, Boucher, Ershow, & Hirch, 2008; Verma, Prasad, 
Elkadi, & Chi, 2011;Watson, Watson, & Pater, 2006; Wiley, Kumar, & Vacek, 2012).  Increased 
pack years of smoking increases the risks of developing PAD, and increases the morbidity and 
mortality of the diagnosis, demonstrating a dose-dependent relationship between the two (Au, 
Golledge, Walker, Haigh, & Nelson, 2013; Hankey, Norman, & Eikelboom, 2006; Katsiki et al., 
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2013; Lee et al., 2011; Paraskevas et al., 2008; Watson, Watson, & Pater, 2006).  Additionally, 
former smokers, or individuals who quit smoking more than 10 years ago, may still have 
increased risk of developing PAD and suffering increased morbidity and mortality (Aboyans et 
al., 2011; Conen et al., 2011; Lu, Mackay, & Pell, 2014; Verma et al., 2011). Finally, smoking 
increases the inherent risks of PAD, including leg amputation, coronary artery disease, stroke, 
and mortality (Madia, 2012; Steffen et al., 2008; Verma et al., 2011).   
There have been few randomized controlled trials (RCTs) of methods of smoking 
cessation specifically for patients with peripheral arterial disease (Hankey et al., 2006; Hennion 
& Siano, 2013; Hennrikus et al., 2010).  However, smoking cessation improves the morbidity 
and slows disease progression by increasing walking distance, doubling five-year survival rates, 
and reducing the incidence of post-operative complications (Au et al., 2013; Hennrikus et al., 
2010; Katsiki et al., 2013).  Clinical practice guidelines offer strong evidence-based 
recommendations supporting smoking cessation interventions for patients with PAD.  There is 
also consensus evidence in favor of screening patients 50 years and older who have a history of 
smoking for PAD (Hennion & Siano, 2013; Layden, et al, 2012; Moyer, 2013).  Unfortunately, 
there is still a large percentage of patients with PAD that are not treated adequately with risk-
factor reduction such as smoking cessation (Aiman et al., 2014; Federman and Kravetz, 2007; 
Lumsden and Rice, 2006). 
Purpose 
 The purpose of this project was to evaluate the feasibility of implementing an 
intervention that identifies current smokers with peripheral arterial disease (PAD) in a small 
specialty practice and providing them with disease-oriented smoking cessation education to help 
prevent disease recurrence or worsening.   
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Significance of the Project 
Smoking is a key modifiable risk factor linked to the development of peripheral arterial 
disease, yet a large percentage of patients who are identified as current smokers do not receive 
smoking cessation education and are under diagnosed and undertreated (Mannava & Money, 
2007; Aiman, et al., 2014).  The goal of this project was to identify current smokers with 
peripheral arterial disease and provide them with disease-oriented smoking cessation education 
to help prevent disease recurrence or worsening.  Providing disease-oriented smoking cessation 
education meant that patients received smoking cessation education that focused on how 
smoking impacts their disease process, and how quitting could improve their symptoms and 
health outcomes.  It was proposed that creating an informational link through disease-oriented 
smoking cessation education may help patients reduce or eliminate their smoking. For example, 
it is known that smoking cessation improves symptoms of PAD such as walking distance and 
claudication and reduces disease recurrence and overall disease morbidity and mortality (Au et 
al., 2013; Katsiki et al., 2013).  Educating patients on the benefits of smoking cessation to 
improve their current symptoms and health likely increased their likelihood of quitting.   
Literature Review and Synthesis 
A systematic review of the literature of the relationship between smoking cessation 
interventions and peripheral artery diseases was conducted in July of 2016 utilizing EBSCOHost 
with CINHAL, HealthSource: Nursing/Academic Edition, Academic Search Complete, 
MEDLINE, PsychINFO and PsychArticles as the selected databases.  “Smoking cessation” and 
“vascular surgery”, “smoking cessation” and “interventions”, “smoking cessation interventions” 
and “peripheral arterial disease”, and “smoking cessation” and “peripheral arterial disease” were 
the mesh terms used for the search.  Peer reviewed, English language articles about smoking and 
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smoking cessation as it related to peripheral arterial disease compromised the inclusion criteria.  
Exclusion criteria included studies that did not relate to smoking or smoking cessation and PAD, 
non-English articles, and non-peer-reviewed articles.  A total of 34 articles were included in this 
brief review of the literature. 
Peripheral Arterial Disease, Smoking, and Smoking Cessation 
Numerous articles related to smoking and peripheral arterial disease were reviewed to 
gain a broad understanding of the literature related to smoking and smoking cessation’s impact 
on peripheral arterial disease.  Peripheral arterial disease is the presence of systemic 
atherosclerosis in arteries distal to the aortic arch (Sontheimer, 2006).  It most often affects the 
arteries that supply the legs, but also can occur in the arms, brain, stomach, kidney, or other vital 
organs (Steffen et al., 2008).  Peripheral arterial disease of the extremities is diagnosed clinically 
by the ankle brachial index (ABI), a diagnostic tool which is assessed with standard protocols 
and calculates the index using a ratio of the highest systolic blood pressure in the arm compared 
with the highest systolic pressure in the legs.  Peripheral arterial disease is defined by an ABI of 
0.90 or less, and the ABI is associated with high sensitivity and specificity (Aboyans et al., 2011; 
Aiman et al., 2014; Aronow, 2007a; Aronow, 2007b; Aronow, 2010; Federman and Kravetz, 
2007; Hankey et al., 2006; Hennion & Siano, 2013; Hennrikus et al., 2010; Hiatt & Krantz, 
2006; Kroger et al., 2009; Lee et al., 2011; Madia, 2012; Moyer, 2013; Simmons, Steffen, & 
Sanders, 2012; Sontheimer, 2006; Steffen et al., 2008; Verma et al., 2011; Watson, Watson, & 
Pater, 2006; Wiley, Kumar, & Vacek, 2012).  Low ABIs have been proven to be an independent 
risk factor of cardiovascular risk and as a predictor for future cardiac events such as coronary 
artery disease, stroke, and death (Aronow, 2007; Hankey et al., 2006; Steffen et al., 2008).   
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Pathophysiology.  Major pathophysiological factors involved in the peripheral arterial 
disease (PAD) include platelet activation and thrombosis, along with arterial stiffness.  As lesions 
develop and increase in complexity, additional factors such as ulceration, rupture, or erosion also 
occur (Alexopoulos, Vlachopoulos, & Stefanadis, 2010; Watson, Watson, & Pater, 2006).  Risk 
factors such as cigarette smoking contribute further to the process due to constriction and 
damage of arteries which potentiates endothelial dysfunction and alters lipoprotein metabolism, 
coagulation, and platelet function (Lee et al., 2011).  Other studies discuss the response to injury 
model of atherosclerosis, which links smoking to endothelial dysfunction, leading to an 
inflammatory host response that leads to vascular remodeling, followed by plaque formation, and 
eventually a complicated atherosclerotic lesion (Haugen, Casserly, Regensteiner, & Hiatt, 2007).  
Passive smoking has also been associated with increased arterial stiffness (Katsiki et al., 2013).  
Current smoking, diabetes, BMI, blood pressure, and cholesterol are the most relevant mediators 
of PAD (Aboyans et al., 2011; Aronow, 2007a; Aronow, 2007b; Aronow, 2010; Federman and 
Kravetz, 2007; Hankey et al., 2006; Hennion & Siano, 2013; Hiatt & Krantz, 2006; Kroger et al., 
2009; Lovell, Myers, Forbes, Dresser, & Weiss, 2011; Lumsden and Rice, 2006; Madia, 2012; 
Mannava & Money, 2007; Moyer, 2013; Muir, 2009; Simmons, Steffen, & Sanders, 2012; 
Steffen et al., 2008; Verma et al., 2011; Watson, Watson, & Pater, 2006; Wiley, Kumar, & Vacek, 
2012). 
Significance.  Peripheral arterial disease (PAD) is associated with a number of 
detrimental health effects such as amputation, heart attack, stroke, and death (Aiman et al., 2014; 
Alexopoulos, Vlachopoulos, & Stefanadis, 2010; Aronow, 2007a; Aronow, 2007b; Aronow, 
2010; Haugen et al., 2007; Hennion & Siano, 2013; Hiatt & Krantz, 2006; Lee et al., 2011; 
Lovell et al., 2011; Moyer, 2013; Muir, 2009; Simmons, Steffen, & Sanders, 2012; Steffen et al., 
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2008; Verma et al., 2011; Watson, Watson, & Pater, 2006; Wiley, Kumar, & Vacek, 2012).  
Notably, people with PAD had a 30% increase in risk of death within five years, and 50% within 
ten years, mostly secondary to myocardial infarction (Dunkley, Stone, Sayers, Farooqi, & 
Khunti, 2007; Hankey et al., 2006).  Additionally, peripheral arterial disease is associated with a 
decreased quality of life (Watson, Watson, & Pater, 2006; Wiggers et al., 2006).  Factors such a 
low socioeconomic status have been associated with higher cardiovascular morbidity and 
mortality when compared to the population and several articles recommend prevention programs 
that specifically target individuals of lower income and education (Aiman et al., 2014; Kroger et 
al., 2009).   
Despite the evidence, many patients with PAD remain untreated (Aiman et al., 2014; 
Mannava & Money, 2007; Verma et al., 2011).  Furthermore, less than one in four Americans 
under 50 were aware of the existence of PAD, and 50% of people did not know that risk factors 
such as diabetes and smoking increased the risks (Steffen et al., 2008).  
Smoking and peripheral arterial disease. Peripheral arterial disease (PAD) has many 
risk factors that contribute to the development and progression of the disease.  Among them, 
smoking has been identified as the single most important modifiable risk factor, known to 
accelerate the development and progression of the disease and symptoms of the disease such as 
claudication, which is pain associated with walking that relieves with rest (Hennrikus et al., 
2010).  As many as 90% of people with PAD have at least one of the risk factors, either smoking 
or diabetes (Federman and Kravetz, 2007).  Diagnosis of PAD in patients who smoke is made up 
to a decade sooner than non-smokers and is associated with earlier onset of symptoms (Muir, 
2009; Verma et al., 2011).  Smoking increased the risk of negative surgical intervention outcomes 
such as graft failure and restenosis by more than double (Aronow, 2007; Federman and Kravetz, 
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2007; Verma et al., 2011; Watson, Watson, & Pater, 2006).  There is a definitive dose-dependent 
relationship with smoking, meaning that patients with greater pack-years of smoking tend to 
have increased morbidity and mortality (Au et al., 2013; Hankey et al., 2006; Katsiki et al., 2013; 
Lee et al., 2011; Paraskevas et al., 2008; Watson, Watson, & Pater, 2006).  Smokers are two to 
four times more likely to develop PAD and more frequently develop advanced disease 
complications such as critical limb ischemia and amputation.  Past smoking, too, had borderline 
association with low ABIs (Aboyans et al., 2011; Conen et al., 2011; Lu, Mackay, & Pell, 2014; 
Verma et al., 2011).  There is evidence that there may be a greater association of smoking to PAD 
than that of coronary artery disease (Katsiki et al., 2013; Lu, Mackay, & Pell, 2014; Madia, 2012; 
Muir, 2009; Steffen et al., 2008; Verma et al., 2011; Watson, Watson, & Pater, 2006).  
Additionally, patients with PAD are less likely to receive appropriate treatment of risk factors 
than those being treated for coronary artery disease (Lumsden and Rice, 2006).   
Smoking cessation.  Smoking cessation is the most cost-effective treatment available for 
the treatment of PAD and is widely accepted as one of the main treatment goals for people with 
PAD who smoke (Katsiki et al., 2013; Wiley, Kumar, & Vacek, 2012). Smoking cessation 
improves walking distance, doubles five-year survival rates, and reduces the incidence of post-
operative complications (Au et al., 2013; Hennrikus et al., 2010; Katsiki et al., 2013).  Continued 
smoking was found to increase the risk of amputation in patients with PAD, specifically those 
with intermittent claudication (Aronow, 2007).  Poor utilization of smoking cessation 
interventions by the medical community has been identified in the literature, with 
recommendations to initiate education on the importance of smoking cessation education earlier, 
such as in undergraduate programs, and integrate it into the curriculum of medical schools 
(Aiman et al., 2014).  Importantly, while the target is to quit smoking, it has been found that 
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cutting down smoking may have beneficial effects (Alexopoulos, Vlachopoulos, & Stefanadis, 
2010).  Also, patients who attempt smoking cessation by switching to chewing tobacco were 
found to have higher rates of mortality than those who chose abstinence (Katsiki et al., 2013). 
Smoking cessation interventions.  Smoking cessation is an effective but underutilized 
treatment for peripheral arterial disease.  Though there have been few randomized controlled 
trials (RCTs) of methods of smoking cessation specifically for patients with peripheral arterial 
disease (Hankey et al., 2006; Hennion & Siano, 2013; Hennrikus et al., 2010); there are 
observational data from studies that indicate that smoking cessation is associated with decreased 
morbidity and reduced disease progression (Hennion & Siano, 2013).  Additionally, clinical 
practice guidelines offer strong recommendations and have strong evidence in favor of smoking 
cessation for patients with PAD (Layden, Michaels, Bermingham, Higgins, & Guideline 
Development Group, 2012; Simmons, Steffen, & Sanders, 2012). In their study of patients with 
PAD, Hennrikus, et al. found that many people who are current smokers are interested in and 
receptive to formal smoking cessation education programs, and many can successfully quit when 
provided with the appropriate resources (2010).  Their intensive intervention helped 21% of 
study participants randomized to the intensive group to quit by utilizing physician advice to quit, 
counseling related to smoking and the link to PAD, motivational interviewing to increase 
motivation to quit, cognitive behavioral therapy counseling to develop a quit plan, and 
information about pharmacological aides for smoking cessation (Hennrikus et al., 2010).  In their 
study of the application of the Chronic Care Model on PAD, a nurse-led team of researchers 
concluded that nursing involvement in empowering people to make life-changing differences 
decreased vascular risk factors and improved outcomes for high-risk population as evidenced by 
significant decreases in the sample’s blood pressure and cholesterol, and 16% of people who 
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smoked at baseline successfully quit with the utilization of smoking cessation counseling at 
every visit and telephone follow-up (Lovell et al., 2011).  
Additional literature on brief interventions.  Brief interventions refer to practices 
which identify and address potential problems during short interactions and motivate individuals 
to change (MDQuit, 2012a).  The National Institute for Health and Care Excellence (NICE) 
guidance offers recommendations related to smoking and brief interventions.  The guidance is 
for practitioners to ask people who smoke how interested they are in quitting, referring those 
who want to quit to support services, offer smoking cessation aides to those unwilling or unable 
to accept a referral, be aware of agencies that offer advice and support on how to stop smoking, 
and have a system in place to know whether patients smoke (NICE, 2006).  For smoking 
cessation, the goal of a brief intervention is to enhance tobacco users’ motivation to change and 
then connect them with evidence-based resources to make their change attempt successful 
(MDQuit, 2012a). Brief interventions are one step of the well-known public health approach 
SBIRT, which stands for screening, brief intervention, and referral to treatment (MDQuit, 
2012b).  
A widely known brief intervention is the “5 A’s” approach to smoking cessation.  The “5 
A’s” is a brief, goal-directed method to address tobacco use with patients with the goal of 
meeting the user’s needs in terms of readiness to quit (MDQuit, 2012a).   The 5 A’s include Ask, 
Advise, Assess, Assist, and Arrange.  The 5 A’s can be tailored to the setting and can involve an 
entire clinic’s staff to accomplish the goal of supporting tobacco users.  When applying the 5 
A’s, clinicians (1) ask about tobacco use at each encounter to identify the patient’s current use 
and past smoking patterns;  (2) advise patients who are active tobacco users to quit in a clear, 
strong, personalized manner; (3) assess a patient’s willingness to quit using a standardized scale, 
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or utilize the stages of change from the Transtheoretical Model of Behavior Change to determine 
the patient’s readiness to change; (4) assist the patient in moving toward a successful quit 
attempt through a chosen intervention; and (5) arrange follow up contact with the patient, either 
in person or via telephone to continue support in the quit attempt (MDQuit, 2012a).   
Evidence-based practice.  Guidelines are collections of evidenced-based 
recommendations related to specific topics that are published periodically to help guide 
management of different diseases in the population.  Several guidelines are available to help 
guide the management of peripheral arterial disease (PAD).  The National Institute for Health 
and Care Excellence (NICE), a United Kingdom based organization recommends that all people 
with peripheral arterial disease receive information, advice, support, and treatment for smoking 
cessation.  For screening, they recommend a thorough vascular history and physical and an 
Ankle-Brachial Index (ABI) study to assess people who display potential symptoms related to 
PAD, with no mention of age or risk factors (Layden et al., 2012).  The American College of 
Cardiology and American Heart Association recommend risk factor modification, including 
smoking cessation, as a major treatment focus.  For screening, they recommend the ankle-
brachial index study for patients with symptoms related to PAD or age 65 and older to be 
screened, along with people 50 years and older who have a history of smoking or diabetes 
(Simmons, Steffen, & Sanders, 2012).  Alternatively, the U.S. Preventative Services Task Force 
does not offer recommendation for screening of asymptomatic adults without a known history of 
peripheral arterial disease, coronary artery disease, chronic kidney disease, or diabetes.  They do, 
however, note that important risk factors to consider include age, diabetes, smoking, 
hypertension, high cholesterol, obesity, and physical inactivity (Moyer, 2013).   
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Synthesis  
Peripheral arterial disease (PAD), an atherosclerotic disease which affects arterial vessels 
distal to the aortic arch impacted by atherosclerotic processes which promote platelet activation 
and thrombosis along with arterial stiffness is defined by an ankle brachial index test less than 
0.90.  Peripheral arterial disease is present in 3-10% of the population and is largely impacted by 
both non-modifiable risk factors such as age and family history, and by modifiable risk factors 
such as smoking.   It is associated with a variety of health problems such as amputations, heart 
attacks, strokes, death, and a decreased quality of life.  Despite its prevalence and ill effects, it is 
widely under diagnosed and undertreated.  Smoking is the top modifiable risk factor for PAD and 
its presence is shown to make a person two to four times more likely to develop the disease.  In 
addition to increasing prevalence, smoking is known to increase the morbidity and mortality 
associated with smoking.  Alternatively, smoking cessation is the most cost-effective treatment 
available for the treatment of PAD and is the main treatment goal for patients with PAD who 
smoke.  Smoking cessation interventions should be a standard of care for healthcare 
organizations which treat patients with PAD.   
Theoretical Framework 
 The Transtheoretical Model of Health Behavior Change supported the implementation of 
this system change.  The model theorizes that health behavior change involves navigation 
through six stages of change to integrate processes and principles of change from different 
theories of intervention.  The model’s foundations are in multiple leading theories of 
psychotherapy and behavior change.   
There are seven assumptions that lay the foundation for the theory (Prochaska & Velicer, 
1997).   The assumptions are as follows: 1) Behavior change is complex and cannot be explained 
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fully by any single theory; 2) behavior change develops over time via a sequence of stages;  3) 
stages of change are stable, yet pliable and open to change;  4) populations cannot move from the 
early stages of change without planned interventions;  5) traditional action-oriented prevention 
programs are best suited for population who are prepared for action and therefore do not meet the 
needs of most at-risk populations; 6) to achieve progress through the stages of change, specific 
processes and principles of change need to be applied at specific stages;  7) biological, social, 
and self-control are all elements which affect chronic behavior patterns (Prochaska & Velicer, 
1997, p. 41).  
The model is defined by several core constructs, including the stages of change, the 
processes of change, and the concepts of decisional balance, self-efficacy, and temptations 
(Prochaska & Velicer, 1997, 39-40).  The six stages of change in the model are precontemplation, 
contemplation, preparation, action, maintenance, and termination.  In the precontemplation stage, 
a person does not intend to make a change in the foreseeable future, either from ignorance or 
discouragement from previous failures.  In the contemplation stage, a person intends to change in 
the near future but is ambivalent towards change because of his or her acute awareness of both 
the pros and cons of change.  The balance between the pros and cons can lead people to remain 
in this stage for long periods of time, and often makes them poor candidates for action-oriented 
programs.  In the preparation stage, people intend to make change in the immediate future and 
have a plan of action for their change, this stage is susceptible to action-oriented programs.  In 
the action stage, people have made specific and overt modifications in their lifestyles which are 
significant and sufficient to reduce risks for disease.  In the maintenance stage, people are 
working to prevent relapse while employing fewer change processes than in the action stage.  
Individuals stay in the maintenance stage from 6 months to 5 years before entering the final 
INCORPORATING SMOKING CESSATION EDUCATION 14 
 
 
stage, termination.  In the termination stage, individuals have zero temptation and reach 100% 
self-efficacy.  Regardless of circumstances, these people have no desire to return to their 
unhealthy behavior, as if they never acquired the habit in the first place.  Less than one in five 
people reach this stage of change.  Relapse is an additional construct related to the stages of 
change and refers to the regression from a higher stage of change to an earlier stage of change.  
People often cycle through the stages of change multiple times prior to successfully achieving 
permanent change (Prochaska & Velicer, 1997, p 39).  See Figure 1. 
 
Figure 1. Transtheoretical Model of Health Behavior Change 
 
There are ten processes of change which have been identified for producing progress 
through change, including consciousness raising, dramatic relief, self-reevaluation, 
Precontemplation 
Contemplation 
Preparation 
Action 
Maintenance 
Termination 
Enter 
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environmental reevaluation, self-liberation, social liberation, counterconditioning, stimulus 
control, contingency management, and helping relationships (Prochaska & Velicer, 1997, p 39-
40).   
The final concepts of the theory are the concepts of decisional balance, self-efficacy, and 
temptations (Prochaska & Velicer, 1997).  Decisional balance relates to an individual’s relative 
weighing of the pros and cons of change.  Self-efficacy is the individual’s self-confidence or 
belief that he or she can cope with specific high-risk situations without relapsing to the known 
unhealthy behavior.  Lastly, temptation refers to the urges to engage in a known unhealthy 
behavior amid challenging situations (Prochaska & Velicer, 1997, p 40). 
Project 
Institutional Review Board 
The project was reviewed and approved as an expedited study by the West Virginia 
University Institutional Review Board (IRB) on December 14, 2017.  There was limited risk to 
the participants.  Informed consent was obtained from those who agreed to participate in the 
evaluative portion of the project.  There was no deception used as part of the project 
implementation.   
Inclusion criteria.  All adults (ages 18 and older) who were (a) active smokers, (b) had 
lower extremity peripheral arterial disease (PAD), (c) were newly diagnosed with PAD, (d) were 
cognitively intact, and (e) spoke English were eligible to participate.  New patients were targeted 
for this project because they had multiple encounters within a short period of time to be exposed 
to the intervention and track behavior change.  The Institutional Review Board (IRB) protocol 
was amended during the enrollment period to include patients with PAD who had developed new 
problems or symptoms related to the disease.  The amendment was approved by the IRB on 
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February 8, 2018.  Patients with new problems or symptoms were added during the enrollment to 
increase sample size and were believed to be very similar to newly diagnosed patients.  The 
inclusion criteria were in line with the theoretical framework of the project, specifically the 
process of consciousness raising, which involves increased awareness about the causes, 
consequences, and cures for a problem behavior.  The hypothesis was that a new diagnosis or 
new problems with the disease would cause these patients to be more receptive to education, and 
more likely to be struck with a call to action, providing a teachable moment.   
Recruitment and enrollment.  The investigator and the medical assistants were 
responsible for identifying individuals who were new patients who were active smokers with 
PAD as recipients of disease-oriented smoking cessation education.  The investigator determined 
which patients met remaining inclusion criteria and asked them of their willingness to participate 
in the evaluative portion of the intervention.  In addition to receiving the smoking cessation 
education, participants who met inclusion criteria were asked to provide additional feedback 
after the intervention and have additional information recorded as part of the evaluation of the 
project.  They were also given an information sheet about the project and informed consent was 
obtained prior to proceeding with the intervention.   
Intervention 
Preparing for the intervention.  Prior to IRB approval, the investigator obtained 
training in motivational interviewing and became certified as a tobacco treatment specialist to 
learn how to better help people successfully quit smoking utilizing evidence-based education and 
therapeutic interventions.  The motivational interviewing skills were used to coach people toward 
behavior change and help move them through the stages of change.  A smoking cessation 
education curriculum was created to provide patients identified as smokers with peripheral 
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arterial disease (PAD) with disease-oriented smoking cessation education tailored to the 
individual’s readiness to change.  Pre-and post-intervention interview questions were developed 
for participants related to smoking and PAD which helped evaluate their understanding before 
and after the intervention.   
Brief intervention plan.  After being screened for inclusion criteria, participants who 
met inclusion criteria received the brief intervention based on the 5 A’s of smoking cessation: 
Ask, advise, assess, assist, and arrange (MDQuit, 2012a).  The investigator (a) asked the 
participant if it was okay to talk about his or her smoking, (b) assessed the participant’s smoking 
by performing a comprehensive smoking history using a standardized tobacco cessation 
interview form, (c) used information from the assessment of the smoking history to advise each 
participant to quit by providing disease-oriented education about smoking and its relationship to 
peripheral arterial disease, (d) assisted participants through education on available cessation 
methods and their proper use and efficacy, and (e) arranged follow up for all participants.  After 
implementation of the 5 A’s, participants were asked to participate in the evaluative portion of 
the intervention.  
Screen patients.  First, patients were screened for inclusion criteria, then asked if it was 
okay to talk about his or her smoking.  Patients were then asked if they would be willing to 
evaluate their experience after the intervention.  The information sheet was reviewed with those 
who agreed to participate, and informed consent obtained.  Next, a brief interview was conducted 
using semi-structured questions to capture the participant’s perspectives on smoking.  The 
interview began by thanking the individual for participating in the project and agreeing to let the 
investigator help him or her stop smoking. The questions from the interview included: (a) What 
are some of the reasons you smoke?, (b) what are the situations or places you find yourself 
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smoking most often?, (c) what thoughts do you have about quitting smoking?, (d) what have you 
done to try to quit in the past?, (e) what stopped you from quitting up to now?, (f) have you ever 
tried to change a different behavior in the past?, (g) what helped you to be successful with 
changing that behavior?, (h) what do you think the hardest barrier to quitting would be today?, (i) 
how successful do you think you would be if you tried to quit now?, (j) what kind of assistance 
do you think you would need?, (k) how do you think your family and friends would react?, (l) 
what is your understanding of the impact of smoking and your health? 
Smoking assessment.  Participant’s smoking was assessed using a standardized tobacco 
cessation interview form.  The comprehensive smoking history included past medical history and 
social history such as occupation, lifestyle habits such as exercise, caffeine consumption, alcohol 
consumption and illicit drug use.  Additional smoking history was gathered including number of 
cigarettes smoked per day, number of years smoking, how much time before they have their first 
cigarette upon waking, and information about cravings such as having trouble not smoking 
where prohibited and if they smoke even if they are ill and in bed most of the day.  The questions 
from this section are from a well-known, validated smoking assessment instrument known as the 
Fagerstrom test for nicotine dependence (NIDA).  This instrument assesses the intensity of 
physical dependence to nicotine based on consumption, compulsion to use, and dependence.  The 
scoring is based on scoring yes/no items with a zero or a one and multiple-choice items from 
zero to three with a final score yield from zero to ten.  Higher scores indicate a more intense 
physical addiction to nicotine, which is an important assessment tool when considering readiness 
and ability to quit (NIDA).  The questions from the scoring instrument were also used to describe 
the participants’ smoking behaviors and tobacco dependence. 
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Readiness to quit was assessed quantitatively by using a self-rating scale and qualitatively 
by asking if participants believed they could quit. These self-rating data were quantified and used 
to describe the sample.  A stage of change was assigned to each participant based on self-rating 
data and qualitative information from the interview.  Additional history gathered included 
reasons for smoking, reasons for wanting to quit, if applicable, and what barriers they could 
identify.  Finally, quit attempt history including number of quit attempts, methods used, and 
family or social support was assessed. 
Advise participants to quit.  Information from the assessment of the smoking history 
was utilized to advise each participant to quit by providing disease-oriented education about 
smoking and peripheral arterial disease (PAD). The 5 R’s helped guide smoking cessation 
interventions; the 5 R’s include relevance, risk, rewards, roadblocks, and repetition (Fiore, et al., 
2008). The education points included (a) smoking is the leading modifiable risk factor associated 
with PAD, and only the individual can change or modify this risk factor; (b) smoking cessation 
can reduce the symptoms related to PAD without any other intervention, and this lifestyle change 
could potentially eliminate the need for medication or surgery; (c) smoking increases the risk of 
complications related to PAD, including complications during, after, or without surgical 
intervention; (d)  recurrent disease after complications can be more difficult to treat, and can lead 
to worsening disease and morbidities such as chronic pain or even limb loss; and (e) people with 
PAD are at an increased risk of having other atherosclerotic diseases such as coronary artery 
disease, which can lead to heart attacks, or carotid or cerebral artery diseases which could lead to 
strokes. 
 After presenting all the educational intervention related to smoking and peripheral arterial 
disease and advising participants to quit smoking as part of their medical management plan, they 
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had the opportunity to decide if they were prepared to commit to quitting at the time of the 
encounter.  None of the participants committed to quitting during this study.  Participants were 
encouraged to keep the education they received in mind, and the investigator summarized the 
information collected and the education given during the encounter.   
Assisting the quit attempt.  Participants were educated using evidence-based tobacco 
cessation methods.  All smoking cessation methods were explained, including “cold turkey”, 
nicotine replacement therapy, and pharmacotherapy.  Relevant data related to efficacy and correct 
utilization of each method was discussed.  After educating on all available options, the 
investigator, together with the individual, made a recommendation for their best option(s).   
Importantly, although none of the participants committed to quitting, the “STAR” 
acronym was discussed.  Participants were educated that once a decision was made to quit 
smoking, they should: 1) set a quit date; 2) tell family, friends, and coworkers about their 
decision; 3) anticipate challenges; and 4) remove tobacco products from the environment 
(Cornuz, 2007). 
 Arranging follow up.  Follow up was arranged for all participants based on their next 
clinic appointment. During this encounter, the smoking history was updated, they received 
additional brief education on the importance of quitting as it related to their disease process, and 
they again were advised to quit using study protocol. Participants who did not have a follow up 
scheduled or missed their follow up were contacted by telephone.  
Participant evaluation of the intervention.  At the three-month encounter, after the 5 
A’s were implemented, the participants who agreed to participate in the evaluative portion of the 
intervention were given a brief interview using semi-structured questions to evaluate their 
thoughts and feelings about the intervention.  Participants were encouraged to provide honest 
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feedback and constructive criticism.  They were informed that there were no right or wrong 
answers to the questions, but that the questions will simply help the investigator better 
understand how to help people manage their smoking and peripheral arterial disease, so they 
have better outcomes.  The questions started with asking how they have done with their smoking 
since the first visit.  Then they were asked how the smoking cessation intervention that was 
provided impacted their smoking and if they made a quit attempt.  Then they were asked what 
about the intervention they found helpful, and what made those aspects of the intervention 
helpful for them.  They were also asked if there were any aspects of the intervention that weren’t 
as helpful, and what made them less helpful in their experience.  They were asked how the 
intervention differed from other smoking cessation interventions they had experienced in the 
past, and if the differences were helpful or not helpful.  Finally, they were asked what they would 
change about the intervention that could make it more beneficial to future patients.  The 
information gathered from the interview was recorded in an electronic log and saved for 
qualitative review during post intervention analysis. 
The Transtheoretical Model and Smoking Cessation 
The theoretical model used for the development and implementation of the intervention 
supported this project because of its historical origin to smoking cessation.  Smoking cessation is 
associated with the Transtheoretical Model, and much of the initial research was related to 
smoking cessation. Since that time, the model has been developed and tailored to many other 
health behaviors.  Utilizing the model to help match the intervention to the stage of change a 
person presented in was important to the project.  Research related to the Transtheoretical Model 
finds that 40% of at risk persons reside in the precontemplation stage of change, while 40% lie in 
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contemplation, and 20% in preparation (Prochaska & Velicer, 1997, p. 41).  Understanding this 
distribution helped tailor the intervention to meet the needs of the patients. 
Of the ten processes of change which help make up the theory, four closely relate to the 
project and are defined further in relation to the project.  Consciousness raising involves 
increased awareness about the causes, consequences, and cures for a problem behavior.  A goal 
of the project was to improve awareness of the disease to patients through disease-oriented 
smoking cessation education.  Interventions that can increase awareness include feedback, 
education, and confrontation.  Self-liberation is both the belief that one can change and the 
commitment to act on that belief (Prochaska & Velicer, 1997, p 40).  Motivation research 
indicates that people with more choices have greater commitment.  For example, patients can be 
provided a choice on how to attempt smoking cessation; action choices for patients are cold 
turkey, nicotine fading, and nicotine replacement.  Counterconditioning requires the learning of 
healthier behaviors that can substitute for problem behaviors, such as nicotine replacement, 
relaxation to counter stress, and assertion to counter peer pressure. Helping relationships 
combine caring, trust, openness and acceptance as well as support for the healthy behavior 
change. Rapport building, a therapeutic alliance, follow up calls, and buddy systems were 
sources of social support experienced during the intervention (Prochaska & Velicer, 1997, p 40).   
Feasibility 
 A major consideration for the practice change was whether it was feasible.  Feasibility for 
the practice change included being cost-effective, having the support of management, and being 
compatible with clinic processes. 
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Budget. The budget for the project included all the costs and the revenue incurred as part 
of implementing the change project in the clinic.  First, the cost of the nurse practitioner 
providing education.  This extra time was calculated using five-minute units calculated at $4.16 
per unit.  The smoking cessation education was conducted after the problem-focused encounter 
and was billed as an “in addition to” service, meaning it was a separately billable service in 
addition to the problem focused visit.  The revenue generated from this additional coding varied 
by payor and length of education provided.  Patients received between three and ten minutes of 
education were billed using the Current Procedural Terminology (CPT) code 99406, while those 
receiving more than ten minutes of education were billed using the CPT code 99407.   Most 
patients were billed using the 99406 CPT code for education between three and ten minutes in 
length, with the average revenue generated among payors being $13.53.  Patients who received 
more than ten minutes of education generated an average of $26.00.  See table 1.   
The cost of the tobacco treatment specialist training was also considered, a one-time cost 
for a course any healthcare professional can take to become qualified to provide and bill for 
tobacco cessation education.  The investigator’s course was obtained for $445.00.  Printed 
materials to implement the project included 5 pages of information per participant which 
summarized information about the intervention for consent purposes.  The printing costs were 
calculated at a rate of $0.10 per page, or $0.50 per participant.  The staff involved in 
implementation also had to be educated and trained on how to screen patients eligible for the 
education.  For this project, about ten minutes was spent educating the medical assistants on the 
developed process and was incorporated into a monthly staff meeting.  The time spent to screen 
each patient was less than one minute and thought to be negligible to the project budget.   
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Cost-benefit.   One of the top factors in feasibility is whether the benefits of the 
intervention outweigh the costs of implementation.  During the study, twenty patients received 
smoking cessation education which was documented as an “in addition to” service in the medical 
record.  Among these patients, sixteen received three to ten minutes of education while four 
received greater than ten minutes of education.  The formula to calculate the revenue is X1 
(number of 3-10 minute interventions) x $13.53 + X2 (number of 10 or more minute 
interventions) x $26.00 = Y (total revenue).  The extra revenue generated was estimated at 
$320.48.  The time the nurse practitioner spent performing the education was calculated based on 
units.  For the analysis, five minutes of time was calculated for patients billed for three to ten 
minutes of education with ten minutes of time calculated for those who received ten or more 
minutes.  The formula for the implementation cost is X1 (number of 3-10 minute interventions) x 
$4.16 + X2 (number of 10 or more minute interventions) x $8.32 = Y (NP implementation cost).   
Using this formula, the nurse practitioner’s time was calculated at a cost of $99.84.  Printed 
materials for the education was calculated at $0.50 per person, for a total of $10.  The formula 
for net revenue is Y1 (total revenue) – Y2 (implementation cost) – printed material cost = net 
revenue.   Therefore, the total additional revenue generated by the intervention exceeded the cost 
by $210.64. 
Table 1. Project Budget 
Expense Per diem N Cost 
Nurse Practitioner $4.16 per unit (5 
minutes) 
16 @ 5 minutes 
4 @ 10 minutes 
$99.84 
Printing $0.10/sheet, 5 sheets 
per participant 
20 $10.00 
Billable Services $13.53 CPT 99406 
$26.00 CPT 99407 
16 @ 99406 
4 @ 99407 
($320.48) 
Total   ($210.64) 
CPT= Current Procedural Terminology, 99406 = CPT code for three to ten minutes education, 99407 = CPT code 
for greater than ten minutes of education 
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Projected costs and benefits.  The pilot project was implemented to a small sub-
population within the clinic.  In one year, there are over 2,800 patient encounters within the 
clinic.  Analysis revealed that 24% or approximately 672 of those patients are active smokers.  
Nearly all these patients would benefit from smoking cessation to improve their vascular and 
overall health and would be potential candidates for smoking cessation education if the project 
was expanded in the clinic.  If each active smoker received smoking cessation education for five 
minutes, it would cost $4.66 per patient while bringing in average revenue of $13.53.  Therefore, 
adding this service as part of standard care for all smokers could generate as much as $5,960 
annually. 
Resources. The resources required for this intervention included a dedicated staff that 
bought into the project, the electronic medical record, and financial resources including the time 
required of the investigator to implement the intervention and the costs of printed materials. 
Staff.  Staff were trained in identifying persons who smoked and had a diagnosis of 
peripheral arterial disease (PAD) so they could be properly identified as appropriate recipients of 
the intervention. Staff also documented an up-to-date smoking history for each participant in the 
medical record to help the investigator with data collection and identifying individuals who met 
inclusion criteria. Finally, the staff scanned relevant data into the electronic medical record. 
The clinic has two to three medical assistants responsible for patient care during each 
clinic day.  During Monday, Wednesday, and Friday clinic times, only the nurse practitioner was 
in clinic, and was easily able to identify patients with PAD and provide the intervention as it was 
designed.  On Tuesdays and Thursdays there were at least two providers in clinic, which is when 
the medical assistants were utilized to help flag patients who met the inclusion criteria to receive 
the intervention, regardless of which provider was seen.   
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Organizational factors. The mission of the practice is to provide excellent care for 
patients with vascular disease and to limit disability associated with their disease.  This aligned 
well with the goals of the project as smoking is a major contributor to the development of 
vascular disease, and to morbidity and mortality after diagnosis.  The practice is an independent 
vascular surgery specialty clinic which is owned and operated autonomously from the hospital; 
this makes cost-effectiveness a priority.  The clinic has a high patient volume with over 100 
patient encounters a week and has three providers, a physician and two nurse practitioners.  The 
number and workload of providers had to be considered when implementing a project that 
required more time for select patient encounters.  Patient volume, proper documentation and 
coding, and efficient utilization of resources are all important to an independent practice which 
requires a positive cash flow.  The project helped increase revenue by providing additional 
services to some patients, which, with proper documentation and coding, provided additional 
reimbursement for the services provided.  
Key site support. The medical director is a vascular surgeon and has shown interest in the 
goals and outcomes of the project throughout the process.  He has offered input and support for 
the project.  He has stated that he would like there to be a publication involved with the project, 
which will be good for dissemination of the outcomes to the medical community.  Other staff 
members, too, bought-in to the project and were instrumental in its success. 
Project Objectives 
 There were five objectives identified for this project.  Two process or formative 
objectives and three outcome or summative objectives.  The two process objectives were: 1) By 
the conclusion of the intervention, 75% of newly diagnosed patients with peripheral arterial 
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disease will have received the defined intervention, and 2) after the study, the participants would 
believe that the intervention was helpful and disease-oriented.     
The three outcome objectives included:  1) After the intervention, smokers who received 
disease-oriented smoking cessation education would have reduced the number of cigarettes they 
smoked daily by at least 50%; 2) after the intervention, smokers receiving the intervention would 
have moved at least one stage forward in their readiness to change, and 3) after the project, a 
cost/benefit analysis would show that the intervention was at least cost neutral. 
Evaluation of Data 
 The project was evaluated using both quantitative and qualitative data to evaluate 
acceptability to participants, effectiveness of the intervention to support smoking cessation, and 
the cost-effectiveness of the intervention within a specialty practice. 
 Process evaluation plan.  The first objective for process evaluation was the qualitative 
evaluation of whether participants found the intervention to be helpful.  This objective was 
evaluated using narrative data gathered from patient interviews pre-and post-intervention.  
Participant’s evaluation of the helpfulness of the intervention was captured through narrative 
responses to the post-intervention interview. Pre and post-intervention stage of change were also 
evaluated using narrative responses.  Responses to the questions from the interview were 
documented in the investigator’s log book.  Data from the investigator’s log book were evaluated 
using thematic analysis.   
The second process objective was that 75% of smokers with a new diagnosis of or 
problem related to peripheral arterial disease (PAD) would receive smoking cessation education.  
This was evaluated utilizing chart review to determine how many people who had both a 
documented smoking history and diagnosis of PAD received smoking cessation education.   
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Outcome evaluation plan.  There were three outcome objectives evaluated for the 
project. Outcome one was evaluated by comparing the number of cigarettes smoked pre-
intervention to number of cigarettes smoked three months after the intervention.  Outcome two 
compared differences in readiness to change prior to the intervention and again three-months 
after the intervention based on the Transtheoretical Model.  Outcome three was evaluated using a 
brief cost-benefit analysis which was performed using data related to the costs of implementing 
the project versus revenue generated from the education as evidenced by a comparison of 
revenues generated by successful documentation, coding, and reimbursement for tobacco 
cessation intervention with the expenditures dedicated to the project. 
Results 
 The analysis of the qualitative and quantitative data revealed interesting information 
about the intervention and its impact on the participants.  The sample is described, followed by 
pre-intervention data, post-intervention data, and finally final outcomes reported by objectives. 
Sample.  During the implementation of the project, there were 394 patients who had a 
diagnosis of peripheral arterial disease (PAD).  Among this group, 102 were active smokers, 101 
were non-smokers, and 191 were former smokers.  Ninety-one patients who had a chief 
complaint of PAD were screened for inclusion in the project.  Twenty-nine active smokers had a 
new diagnosis or problem related to PAD.  Among these, 20 had documented education related to 
smoking and PAD.  The final sample included 9 participants who were willing to talk about their 
smoking and evaluate the intervention.   
Nine participants, 5 males and 4 females, agreed to evaluate the evaluation component of 
this project.  All participants were white, with an average of 59.1 years of age (range 52-67 years 
of age). Participants smoked an average of 40 years (range 25-50 years) at about one pack (19.77 
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cigarettes) a day (range 8-35 cigarettes).  There were four participants with Medicare and three 
with Medicaid, the other two had private insurance.   
 Pre-intervention assessment.  As a group, the sample was in the contemplation stage at 
their first visit, with participants ranging from pre-contemplation to action stage. Their 
Fagerstrom score averaged 5.3 (range 2-8), which represents moderate dependence to nicotine 
(NIDA).  The group response to the question whether they were ready to quit had average 6.8 
(range 1-10). 
 Pre-intervention interview analysis. Descriptive data from the pre-intervention interview 
revealed information about why participants smoked and other information about their smoking 
history.   
Smoking behaviors and quit attempts.  There were some common themes among 
participants for reasons they smoked, such as stress (7), habit (4), and inability to quit (5). 
Participants reported smoking the most in their car (4), after meals (4), and in social settings (3).  
Many believed they needed to quit (8), either for their health (5), because their family wants 
them to (3), or because it is expensive (4).  Most of the participants had attempted to quit in the 
past (8), with everyone having attempted to quit cold turkey in the past, and many others having 
tried some form of nicotine replacement (6).  Three participants had tried a pharmacologic 
cessation aid, and two others stated they had thought about it but were afraid of side effects.   
Motivators and barriers.  More than half of the patients had successfully changed a 
different behavior (5), most of those having quit alcohol (3), with one having been previously 
dependent on pain medication.  Health (3) and necessity (2) were the most commonly cited 
reasons these participants gave for being successful.  Stress (6), previous failures (3), and 
withdrawal symptoms (4) were the main reasons participants gave for not quitting smoking to 
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date.  The participants’ most difficult barriers to quitting were similar to reasons they smoke and 
what has stopped them up to now; they cited stress (6), habits (4), and years smoking (3) as 
biggest barriers.   
Smoking cessation self-efficacy. The participants were not optimistic about their ability to 
quit, with only a few believing they could successfully quit with help (3). 
Smoking cessation facilitators.  Mentorship from former smokers (2), willpower (3), and 
environmental changes such as friends and family quitting (3) were all common answers to what 
assistance would be needed to successfully quit.  All but two participants stated that friends and 
families would be supportive of quitting smoking, with the other participants being unsure if they 
could get their spouse or significant other to quit with them or “buy in” to their quit attempt (2). 
 Impact of smoking and health. The participants had difficulty answering the question of 
what their understanding was about the impact of smoking and their health.  Prompting was 
required for many to provide a response to the open-ended question.  Participants believed that 
smoking was not good for their health.  Most stated that it affected their breathing (5), and a few 
stated they were worried about the risk of a heart attack (4).  None responded that their current 
issues with peripheral arterial disease may be related to smoking.  Interestingly, several (3) 
participants stated that they believed it was too late to change their health by quitting smoking, 
with one stating that “something had to kill him”, and it wasn’t worth quitting at his age.   
 Post-intervention.  After the intervention, the group moved forward in their readiness to 
change, from the contemplation stage to the preparation stage.  They ranged from the pre-
contemplation stage to the action stage.  One patient quit smoking during the study for about 
one-month but returned to smoking three cigarettes daily by the three-month follow up.  Another 
patient reported as quit at the three-month follow up encounter, however she had just been 
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discharged from the rehab facility where she was unable to smoke.  The group averaged about 
19.8 cigarettes a day at the first visit, which decreased to about 7.75 cigarettes (range 0-10 
cigarettes) by their three-month follow-up.   
 Post-intervention interview analysis.  A thematic analysis was performed on interview 
data collected during the three-month follow-up interview.  Information from the interviews was 
used to identify themes related to participants’ thoughts on whether the intervention was helpful.  
As a group, the majority answered that the intervention was helpful (5), while two participants 
stated they could not recall the education to make a judgement.  There were three recurring 
themes from the question about what was helpful: 1) Conversation (3), 2) fear or stress (3), and 
3) thinking (3).  The fear could be a positive response, as one patient said the intervention was 
eye-opening and put the “fear of God” in him to make a change for his health.  The following 
themes reflected what the group did not find helpful: 1) Length of talking (3), 2) too much 
information (2), and 3) stress (5).  One participant stated no provider had spent “that much time 
talking” to her about smoking, and that our conversation was the first time she became mad at a 
provider over the conversation about smoking.  Their thoughts on the difference in this 
intervention from others included: 1) Longer conversation (4), 2) not forceful (3), and 3) 
thought-provoking (3).  For those who offered feedback on what could be changed about the 
intervention, the recommendations to stay brief (2), provide more written information (2), and 
creating a “cigarette 12 steps program” (1) were the most enlightening.   
 The interviews also revealed other information that was meaningful qualitative data for 
this study.  The conversations with participants revealed actions they had taken related to 
smoking over the three-month period, barriers they faced, and successes they had.  Many patients 
admitted to thinking more about their smoking and had made some attempts to cut back (4).  
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Two patients had called the quitline and obtained nicotine replacement products to try to help 
them reduce their smoking.  Participants identified stress as a big barrier to quitting.  Most 
participants identified the first cigarette of the day as the most difficult to eliminate and were 
unsure of what they could do to change habits to eliminate all cigarettes smoked throughout the 
day (4).  Several participants pointed out that other conditions such as chronic obstructive 
pulmonary disease (COPD) made them more fearful and motivated them to attempt to quit (3).  
One participant specifically states that her lung doctor got her to commit to quitting after a 
hospitalization from COPD.  She admitted that this intervention likely opened the door to 
thinking more about her smoking, but that the COPD scare really pushed her through.    
Process and outcome evaluation.  The final evaluation of the outcomes revealed 
whether the objectives of the project were met. 
Process evaluation.  There were two process objectives which were evaluated. 
Objective 1.   Twenty-nine patients presented with a new or newly complicated diagnosis 
of peripheral arterial disease. Among those, 20 had documentation of smoking cessation 
education during their visit.  Therefore, about 69% of patients who met inclusion criteria 
received the intervention, short of the goal of 75%.  
Objective 2.  After the study, most of the participants (6) believed that the intervention 
was helpful and several stated that the content about their disease was thought provoking and 
made them more concerned about their smoking (3).        
Outcome evaluation.  There were three outcome objectives which were evaluated. 
Objective 1.  After the intervention, participants who received disease-oriented smoking 
cessation education reduced the number of cigarettes they smoked daily from an average of 
19.77 to 7.75, a difference of 60.8%, greater than the goal of 50%.   
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Objective 2.  Participants who received the intervention moved forward 1.0 stages, which 
met the goal of moving at least one stage forward in their readiness to change.  
Objective 3.  After the project, a cost/benefit analysis revealed that the intervention was 
cost-effective; the total additional revenue generated by the intervention outweighed the cost by 
$210.64.   
Discussion and Recommendations 
Challenges 
 Many of the goals of the intervention were met and positive quantitative and qualitative 
data were revealed during the study.  However, there were several challenges met during 
implementation that limited the study and are addressed in this section. 
Sample size.  During project implementation, the educational intervention was provided 
to twenty patients in the clinic.  Nine patients agreed to participate in the project evaluation.  
Notably, the small sample size limited both quantitative and qualitative evaluation.  Additionally, 
one patient could not be reached for telephone follow up and did not attend their follow up 
appointment, leaving only eight patients for final evaluation.  Despite the small sample size, this 
pilot study provided useful information about the feasibility and potential effectiveness of 
implementing a smoking cessation education program into a specialty clinic setting.   
Barriers to recruitment.  There were unforeseen circumstances which led to a smaller 
than expected sample size for this project.  First, during implementation it was discovered that 
fewer patients than anticipated were active smokers.  Many patients had quit smoking, but it was 
not reflected in their medical records.  Additionally, there are many patients, especially older 
patients, who deny any history of smoking.  To counter this barrier, Institutional Review Board 
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approval was obtained to modify the inclusion criteria to include patients with new problems 
related to peripheral arterial disease to increase the number of individuals eligible to participate.   
Importance of proper documentation.  Clinicians in all practice settings should take 
extra care to ensure that proper documentation of patient history occurs at every encounter.  The 
implementation of this change project revealed that many patients had outdated information in 
the social history related to smoking, such as being documented as a current smoker although 
they had quit.  This information should be considered when deciding whether an intervention 
could be cost-effective in a clinical setting, as having fewer smokers than anticipated will 
decrease the available population to deliver an intervention.   
Results and Implications 
 The analysis of the qualitative and quantitative data revealed interesting information 
about the intervention and its impact on the participants.  Further discussion regarding the pre-
and -post-intervention data is discussed in this section.  
Analysis of pre-intervention qualitative data.   The pre-intervention interview and other 
intake information provided useful narrative data regarding where patients were prior to the 
intervention.  The interview provided insights into their smoking behaviors and previous quit 
attempts, motivators and barriers to quitting, their self-efficacy regarding smoking cessation, and 
smoking cessation facilitators. 
Smoking behaviors and quit attempts.  There were some common themes among 
participants for reasons they smoked, their behavior patterns with smoking, and their previous 
attempts to quit.  The data suggests that smoking affects many people in similar ways, but it does 
not make it easier to quit.  An important consideration from the data is that many smokers want 
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to quit, and most have tried in the past.  When implementing an intervention, gaining an 
understanding of your sample will help better tailor the intervention to their needs.  
Motivators and barriers.  Stress, previous failures, and environmental barriers are all 
common reasons that people fail to quit.  Stress is present in everyone’s lives, although it varies 
widely in types and amounts.  Addressing reasons for stress and teaching alternative coping 
mechanisms can help break down this common barrier.  Common environmental factors include 
smoking in the car, after meals, or in social settings.  These common smoking triggers can be 
individually explored with follow-up questions to gather more about the underlying reasons that 
may be leading to recurrent failures to quit.  Expanding on the interview can open more 
opportunities to implement the 5 R’s, which incorporate the concepts of relevance, risk, rewards, 
roadblocks, and repetition.   
Smoking cessation self-efficacy. Smokers and providers not understanding the 
underlying reasons patients smoke and why previous quit attempts have failed can lead to the 
issue of poor self-efficacy, or individuals not believing they can successfully quit, which was 
reflected in the data.   
Smoking cessation facilitators. The participants offered some insight into poor self-
efficacy could be encountered, such as utilizing former smokers to mentor current smokers 
toward a successful quit.  Otherwise, serious health issues or “necessity” may be the only strong 
motivating factors for patients to quit.  The participants in this study attributed previous behavior 
changes such as quitting alcohol or prescription drugs to these reasons. The challenge with 
tobacco addiction, when compared to alcohol or opioid or drug abuse is that it doesn’t alter 
people’s behavior or lead to legal problems, leaving only serious health issues as strong 
motivators for people to quit, which are often later stages of disease.   
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Exploring possible “calls to action” or reasons to quit is part of the 5 R’s and is a major 
consideration for individuals developing a smoking cessation intervention.  The participants in 
this study had low self-efficacy from previous failures and were not strongly motivated to quit 
for their peripheral arterial disease, but they did reduce their smoking over the course of the 
study.  The literature discusses the dose-dependent relationship between smoking and peripheral 
arterial disease, and although complete cessation is ideal, significant reductions should be 
valued.   
Health priorities.  Health, wellness, and quality of life are all important aspects to 
consider when developing and implementing health promotion or disease prevention 
interventions.  It is important, however, to consider that individuals have different priorities 
regarding their health and lifestyle choices.  Educating individuals about their behavior and why 
it is unhealthy may be ineffective if they are already aware of the information but do no not care 
to change.  This was demonstrated during this intervention, as one participant explained that he 
thought it was too late to quit and he didn’t have the desire to.  His belief was that something had 
to kill him, and it wasn’t worth quitting at his age.  Alternatively, there were participants who 
found the disease-oriented smoking cessation education to be thought-provoking, with some 
having a fearful response to how continued smoking may impact their disease in the future.  For 
these individuals, education may lead to a call to action to change their behavior.    
Analysis of post-intervention qualitative data.  The sample for the study found the 
intervention helpful, but notably, many found it hard to recall the intervention in detail.  A larger 
group may reveal more insights into what was helpful and why.  There were many important 
ideas that emerged from the narrative data gathered from participants about the intervention, 
such as opinions on the length of the conversation, the amount of written information desired, the 
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willingness of people to try pharmacological options for smoking cessation, and individual’s 
priories regarding health. 
Length of conversation.  Participants in the study expressed different opinions on the 
length of the conversation during the smoking cessation education.  The recurring theme was that 
in investigator spent more time discussing smoking cessation than they were accustomed to.  
What differed was participants opinions and preferences on whether the conversation was too 
long.  When developing or implementing an intervention related to uncomfortable topics, one 
must consider participants’ preferences on length of conversation and be able to tailor the 
intervention based on how long an individual is willing to spend on the topic.  Being able to read 
cues that you are losing an individual’s attention should bring you to a stopping point where you 
can summarize information, then potentially provide a written summary of the education.   
Written information.  The amount and type of written information provided during an 
intervention is another important consideration.  Written information can be a good tool to 
reinforce, summarize, or supplement verbal education provided to patients.  Participants in the 
study offered recommendations for the amount and type written information for the study.  Some 
recommended more than the summary the was provided to be included.  Other options could 
include activities for participants to complete at home between encounters or “fact sheets” about 
smoking in general.  These are often included in community smoking cessation classes and could 
be useful in the clinic setting as well.  Additionally, one participant recommended a “12 step for 
cigarettes”.  This could be developed and put into written for and provided to patients as part of 
supplemental information and/or incorporated into the verbal education. 
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Cessation aides.  There are multiple options for approaches smokers can utilize for 
smoking cessation.  For this intervention, all options were discussed as available options, 
including “cold turkey”, nicotine replacement, or pharmacological aides.  Most participants had 
tried both quitting cold turkey or nicotine replacement in the past.  As a group they seemed 
comfortable with these methods, although they were not confident in their efficacy given 
previous experiences.  Alternatively, pharmacological aides had only been utilized by three of the 
participants.  Among them, two had some success, but one stopped the medication because of 
side effects.  Two other participants expressed concern with the potential side effects of the 
pharmacological agents and were against their use.  When implementing an intervention, it is 
important to consider all the alternatives available for intervention.   
Continuation of the Project 
 This pilot project provided insights into the feasibility of implementing a brief but 
intensive intervention into a specialty clinic setting.  At a vascular surgery practice, virtually all 
conditions treated are impacted by smoking, and anyone who smokes can be educated on the 
impacts of smoking and their disease process with only small modifications in delivery based on 
the condition.  Implementing this education as the standard of care for all active smokers within 
the practice will help improve the quality of care, follow evidence-based guidelines, and increase 
practice revenue.   
 The project also provided a better understanding of the barriers to incorporating more 
tobacco cessation education into the practice and what changes would improve care delivery.  
First, more than one provider within the clinic should be trained in tobacco cessation to be able 
to reach more patients during high volume clinic days.  Alternatively, a non-provider could be 
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trained as a tobacco treatment specialist and be designated to follow the treatment protocol and 
educate patients identified as appropriate recipients of tobacco cessation education.  
Implementation in other settings.  Education on smoking cessation and assistance with 
quitting are typical in the primary care setting, but research shows that it is lacking in specialty 
clinic settings.  This project showed that with proper education of staff and commitment to the 
goal of improving patient care, effective smoking cessation education can be provided in the 
specialty setting in a cost-effective way.  Reimbursement is possible for tobacco cessation 
education in specialty clinics with proper documentation and coding if performed by a trained or 
licensed professional.  A variety of medical professionals qualify to be tobacco treatment 
specialists, from physicians to medical assistants, however formal training is not required for 
reimbursement from licensed professionals.   
Attainment of DNP Essentials 
Scientific Underpinnings for Practice 
 The development and implementation of this change project required research of the 
pathophysiology of peripheral arterial disease and smoking along with evidenced-based 
guidelines for implementing smoking cessation interventions across a variety of settings.  
Secondly, a new practice approach for smoking cessation intervention in a specialty clinic setting 
was developed, implemented, and evaluated.   
Organizational and Systems Leadership for Quality Improvement and Systems Thinking 
 The developed intervention was a problem-focused clinical practice initiative intended to 
improve the quality of care delivered within the organization.  The cost-effectiveness of the 
practice change initiative was analyzed to ensure long-term feasibility. 
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Clinical Scholarship and Analytical Methods for Evidence-based Practice 
 Clinical scholarship was demonstrated through the design and implementation of 
processes to evaluate the outcomes of the practice change initiative against standard care.  
Analytical methods were used to appraise existing literature to determine the best methods and to 
implement and evidence-based intervention.   
Information Systems/Technology and Patient Care Technology for the Improvement and 
Transformation of Health Care 
 An important piece of the development and implementation of the project was evaluation 
of how healthcare technology and the electronic medical record could be utilized to facilitate 
efficient implementation of the change project.   
Health Care Policy for Advocacy in Health Care 
 As part of the efforts to fully understand health care policy for advocacy in health care, 
the centers for Medicaid and Medicare Services and other health insurance policy information 
regarding coverages and billing for smoking cessation were researched.  Information from the 
project and education provided was documented in the medical record based on available 
guidelines for billing and coding.  This information is useful to other providers in the 
participants’ care team and to demonstrate to insurances that smoking cessation is being 
discussed or attempted.  
Interprofessional Collaboration for Improving Patient and Population Health Outcomes 
 An interprofessional team was led by the student to analyze existing practices and 
develop a new standard of care for implementation in the practice setting.  Effective 
communication and collaboration skills were utilized in implementing best practice using the 
chosen transtheoretical model.  
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Clinical Prevention and Population Health for Improving the Nation’s Health 
 The student synthesized concepts, including psychosocial dimensions and cultural 
diversity, related to clinical prevention and population health in developing, implementing, and 
evaluation interventions to address health promotion and disease prevention efforts in smoking 
cessation.  Additionally, the care delivery model in the project from perspective of community 
health and the cultural and socioeconomic dimensions of health was evaluated. 
Advanced Nursing Practice 
The student developed and implemented an intervention and evaluated it for links among 
practice, organizational, population, fiscal, and policy issues with a focus on nursing science and 
other sciences.  The intervention involved developing and sustaining therapeutic relationships 
with patients and health professionals to facilitate optimal care and patient outcomes. 
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Appendix I. Tobacco Cessation Interview Form  
Tobacco Cessation Interview Form
TOBACCO USE
1. How soon after you awaken do you smoke your first cigarette?
After 60 minutes (0) 
31-60 minutes (1)
6-30 minutes (2) 
Within 5 minutes (3)
2.
Do you find it difficult to refrain from smoking in places where it is 
forbidden?
No (0)                             
Yes (1)
3. Which cigarette would you hate the most to give up?
The first in the 
morning (1)  
Any other (0)
4. How many cigarettes per day do you smoke?
10 or less (0)
11-20 (1)
21-30 (2)
31 or more (3)
5.
Do you smoke more frequently during the first hours after 
awakening than during the rest of the day?
No (0)                             
Yes (1)
6.
Do you smoke even if you are so ill that you are in bed
 most of the day?
No (0)                             
Yes (1)
READINESS TO CHANGE
How badly do you want to 
quit now (scale 1-10)
Do you think you can successfully quit with help?
STAGE OF CHANGE
c Precontemplative
c Contemplative
c Planning
c Active
c Maintenance
c Relapse
c Recycle
TOBACCO USE QUESTIONNAIRE
Why do you smoke?
Why do you want to quit?
What are some barriers to quitting?
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QUIT ATTEMPT HISTORY
Have you ever tried to quit prior to today?
What methods did you use?
Did you have family/friend support?
TRIGGERS
ADDITIONAL HISTORY DISCUSSED
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Appendix II. Descriptive Questions 
1. How many patients in sample smoke their first cigarette… 
a. Within 5 minutes of waking up? 
b. 6-30 minutes within waking up? 
c. 31-60 minutes within waking up? 
d. After 60 minutes of waking? 
2. How many patients find it difficult to refrain from smoking in places where it is 
forbidden? 
a. How many do not find it difficult to refrain? 
3. How many patients find the first cigarette in the morning the hardest to give up? 
a. How many find a different cigarette the most difficult? 
4. How many cigarettes a day does patient smoke? 
a. 10 or less 
b. 11-20 
c. 21-30 
d. 31 or more 
5. How many patients fine that they smoke more frequently in the first hours after 
awakening than during the rest of the day? 
6. How many patients said they would smoke even if they were ill and in bed most of the 
day? 
a. How many said they wouldn’t? 
7. How many patients did not want to quit smoking at all? (1-2/10) 
a. How many would consider quitting? (3-6/10) 
b. How many are considering quitting? (7-8/10) 
c. How many want to or are trying to quit? (9-10/10) 
8. How many patients believe they can successfully quit smoking with help? 
a. How many do not believe they can quit? 
9. How many patients have tried quitting in the past? 
a. How many have never tried? 
10. How many patients have tried quitting cold turkey? 
a. With nicotine replacement therapy? 
b. With prescription medication? 
c. With cognitive behavioral therapy? 
d. With combination therapy? 
11. Average years smoking 
a. Range 
12. Number of cigarettes smoked per day 
a. Range 
b. average 
 
INCORPORATING SMOKING CESSATION EDUCATION 45 
 
 
Appendix III. Qualitative Interview Questions 
 
Pre-Intervention 
1. What is your understanding of the impact of smoking and your health? 
a. Perception of risk 
2. What are your reasons for smoking? 
3. What are your thoughts about quitting smoking? 
a. Do you want to quit? 
b. Have you tried? 
4. What have you tried to quit smoking in the past?  
5. What do you see as barriers to quitting smoking? 
6. Do you think that you can quit smoking? 
7. How do you think your family and friends will react to your commitment to quit 
smoking? 
 
Post-Intervention 
1. Do you think that the smoking cessation intervention we provided was helpful to your 
quit attempt?   
2. What about the intervention did you find helpful? 
3. What about the intervention did you find as not helpful? 
4. How was this intervention different from other tobacco cessation interventions you have 
experienced in the past? 
5. What would you change about the intervention to improve it for future patients? 
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